再狭窄:治療薬のグローバル治験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Restenosis Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Restenosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Restenosis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Restenosis to Cardiovascular Clinical Trials 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Restenosis 23
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Restenosis Therapeutics Clinical Trials 28
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Sarepta Therapeutics, Inc. 31
Clinical Trial Overview of Sarepta Therapeutics, Inc. 31
Abbott Laboratories 32
Clinical Trial Overview of Abbott Laboratories 32
Novogen Limited 33
Clinical Trial Overview of Novogen Limited 33
Mercator MedSystems, Inc. 34
Clinical Trial Overview of Mercator MedSystems, Inc. 34
Chugai Pharma USA, LLC 35
Clinical Trial Overview of Chugai Pharma USA, LLC 35
Celgene Corporation 36
Clinical Trial Overview of Celgene Corporation 36
C. R. Bard, Inc. 37
Clinical Trial Overview of C. R. Bard, Inc. 37
Angelini Group 38
Clinical Trial Overview of Angelini Group 38
Clinical Trial Overview of Top Institutes / Government 39
Jinling Hospital 39
Clinical Trial Overview of Jinling Hospital 39
Deutsches Herzzentrum Munchen 40
Clinical Trial Overview of Deutsches Herzzentrum Munchen 40
University Hospital Tubingen 41
Clinical Trial Overview of University Hospital Tubingen 41
University of Rome II 42
Clinical Trial Overview of University of Rome II 42
University of Roma La Sapienza 43
Clinical Trial Overview of University of Roma La Sapienza 43
Hiroshima University Hospital 44
Clinical Trial Overview of Hiroshima University Hospital 44
French Cardiology Society 45
Clinical Trial Overview of French Cardiology Society 45
Samsung Medical Center 46
Clinical Trial Overview of Samsung Medical Center 46
Nantes University Hospital 47
Clinical Trial Overview of Nantes University Hospital 47
Medical University of Vienna 48
Clinical Trial Overview of Medical University of Vienna 48
Five Key Clinical Profiles 49
Appendix 86
Abbreviations 86
Definitions 86
Research Methodology 87
Secondary Research 87
About GlobalData 88
Contact Us 88
Disclaimer 88
Source 88


【レポート販売概要】

■ タイトル:再狭窄:治療薬のグローバル治験動向(2014年下半期)
■ 英文:Restenosis Global Clinical Trials Review, H2, 2014
■ 発行日:2014年9月10日
■ 調査会社:GlobalData
■ 商品コード:GDHC2327CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。